Mh. Vesaluoma et Tt. Tervo, TENASCIN AND CYTOKINES IN TEAR FLUID AFTER PHOTOREFRACTIVE KERATECTOMY, Journal of refractive surgery, 14(4), 1998, pp. 447-454
BACKGROUND: Basic knowledge of the substances involved In wound healin
g after photorefractive keratectomy (PRK) is essential for development
of pharmacological intervention. We present preoperative and postoper
ative analysis of tear fluid extracellular matrix proteins and cytokin
es after PRK. METHODS: Tear fluid samples from 70 patients (72 eyes) w
ho had PRK (38 women and 32 men, mean age 31.5 yr) were studied, Sampl
es from 18 patients (18 eyes) were analyzed in two different studies.
RESULTS: Mean preoperative tear fluid flow in the collection capillary
(volume divided by tear collection time) varied.from 4.5 to 22.5 mu l
/min in five series of patients. It increased significantly during the
first two postoperative days (range of means, 55.5 to 88.8 mu l/min,
p < 0.01), and decreased to the preoperative level by day 7 (range of
means, 9.7 to 18.2 mu l/min).The tenascin and cytokine release rates i
ncreased significantly during the first two days after PRK and returne
d to the preoperative level by day 7, Mean +/- standard error for tena
scin: day 0 (5.2 +/- 1.9 ng/min); day 2 (22.7 +/- 6.1 ng/min; p=0.02).
Mean +/- standard error for HGF: day 0 (3.2 +/- 0.7 pg/min); day 1 (2
2.8 +/- 4.2 pg/min; p=0.0003). Mean +/- standard error for TGF-beta 1:
day 0 (63.3 +/- 19.6 pg/min); days 1-2 (826.2 +/- 253.7 pg/min; p=0.0
01). Mean +/- standard error for VEGF: day 0 (166.0 +/- 29.6 pg/min);
days 1-2 (824.4 +/- 165.1 pg/min; p=0,0007). Mean +/- standard error f
or PDGF-BB: day 0 (0.42 +/- 0.19 pg/min); day 2 (27.6 +/- 5.8 pg/min;
p=0.0000). Mean +/- standard error for TNF-alpha: day 0 (9.5 +/- 2.8 p
g/min); day 2 (28.6 +/- 5.9 pg/min; p=0.003). Excluding PDGF-BB, all s
ubstances studied were present in normal human tear fluid. PDGF-BB was
present in only 17% of the preoperative samples. CONCLUSION: Corneal
wounding induces an increased release of several growth modulating cyt
okines which may be involved in healing processes.